Liquidia Corporation
LQDA • NASDAQ
Liquidia Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Roger A. Jeffs, with a market cap of $3.1B.
CEORoger A. Jeffs
Next Earnings
Upcoming earnings announcement for Liquidia Corporation
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.38
Revenue Estimate
$113.5M
Earnings History
Past 12 earnings reports for Liquidia Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | $0.15Est: $0.33 | -54.5% | $92.0MEst: $79.3M | +16.1% |  10-K |
| Nov 3, 2025 | Q3 2025 | -$0.04Est: -$0.38 | +89.5% | $54.3MEst: $17.6M | +209.6% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.49Est: -$0.41 | -19.5% | $8.8MEst: $3.9M | +125.9% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.45Est: -$0.42 | -7.1% | $3.1MEst: $3.2M | -3.4% | 10-Q |
| Mar 19, 2025 | Q4 2024 | -$0.46Est: -$0.40 | -15.0% | $2.9MEst: $4.6M | -36.6% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.39Est: -$0.37 | -5.4% | $4.4MEst: $4.2M | +6.2% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.37Est: -$0.34 | -8.8% | $3.7MEst: $9.5M | -61.3% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.54Est: -$0.32 | -68.8% | $3.0MEst: $4.4M | -32.3% | 10-Q |
| Mar 13, 2024 | Q4 2023 | -$0.42Est: -$0.23 | -82.6% | $4.5MEst: $4.7M | -4.2% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.24Est: -$0.21 | -14.3% | $3.7MEst: $4.3M | -15.1% | — |
| Aug 10, 2023 | Q2 2023 | -$0.36Est: -$0.16 | -125.0% | $4.8MEst: $4.4M | +8.0% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.18Est: -$0.16 | -12.5% | $4.5MEst: $4.0M | +13.7% | — |